Decoy Therapeutics Inc. files prospectus
- Up to 2,368,868 shares of common stock
- New Warrants issued on Sept 23, 2026
- Cash balance as of Sept 30, 2026: $8.0 million
SLRX
Decoy Therapeutics Inc. SEC filings
Every EDGAR filing for Decoy Therapeutics Inc. (SLRX), newest first, with AI summaries and stories.
- Ticker
- SLRX
- CIK
- 1615219
- Sector
- Biotech and pharma
- Latest filing
- 2d
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE424B3Decoy Therapeutics Inc.DCOYLIVE NOTABLES-1Decoy Therapeutics Inc.DCOYLIVE Decoy Therapeutics files S-1 for stock offering
- Filed S-1 on 2026-10-07
- Up to 2,368,868 shares of common stock
- Private placement closed on 2026-09-23
ROUTINE8-KDecoy Therapeutics Inc.DCOYLIVE ROUTINE8-KDecoy Therapeutics Inc.DCOYLIVE ROUTINE4Decoy Therapeutics Inc.DCOYLIVE 10 insider filings
Jonathan I Lieber, insider filing for DCOY
Show all 10
- 4Insider filing for DCOY
- 4Insider filing for DCOY
- 4Insider filing for DCOY
- 4Insider filing for DCOY
- 4Insider filing for DCOY
- 4Insider filing for DCOY
- 4Insider filing for DCOY
- 4Insider filing for DCOY
- 4Insider filing for DCOY
- 4Insider filing for DCOY
Jonathan I Lieber, reporting
ROUTINESCHEDULE 13GDecoy Therapeutics Inc.DCOYLIVE Ownership stake disclosure by ARMISTICE CAPITAL, LLC
ARMISTICE CAPITAL, LLC, filed by
NOTABLE10-QDecoy Therapeutics Inc.DCOYLIVE ROUTINEDEF 14ADecoy Therapeutics Inc.SLRXLIVE ROUTINEDEFA14ADecoy Therapeutics Inc.SLRXLIVE ROUTINE3Decoy Therapeutics Inc.SLRXLIVE Patricia G. Gauthier, new insider at SLRX
Patricia G. Gauthier, reporting
ROUTINEPRE 14ADecoy Therapeutics Inc.DCOYLIVE ROUTINEEFFECTDecoy Therapeutics Inc.DCOYLIVE ROUTINE424B3Decoy Therapeutics Inc.SLRXLIVE ROUTINE8-KDecoy Therapeutics Inc.SLRXLIVE NOTABLES-1Decoy Therapeutics Inc.DCOYLIVE ROUTINE8-KDecoy Therapeutics Inc.SLRXLIVE ROUTINEEFFECTDecoy Therapeutics Inc.SLRXLIVE ROUTINERWDecoy Therapeutics Inc.SLRXLIVE ROUTINEDEFA14ADecoy Therapeutics Inc.DCOYLIVE ROUTINEDEF 14ADecoy Therapeutics Inc.DCOYLIVE ROUTINE8-KDecoy Therapeutics Inc.DCOYLIVE NOTABLE10-QDecoy Therapeutics Inc.SLRXLIVE ROUTINE10-K/ADecoy Therapeutics Inc.SLRXLIVE ROUTINES-8Decoy Therapeutics Inc.SLRXLIVE ROUTINE8-KDecoy Therapeutics Inc.SLRXLIVE NOTABLE10-KDecoy Therapeutics Inc.SLRXLIVE ROUTINE8-KDecoy Therapeutics Inc.SLRXLIVE ROUTINE8-KDecoy Therapeutics Inc.SLRXLIVE ROUTINESCHEDULE 13G/ADecoy Therapeutics Inc.SLRXLIVE Ownership stake disclosure by CVI Investments, Inc. (amended)
CVI Investments, Inc., filed by
ROUTINEDEF 14ASalarius Pharmaceuticals, Inc.SLRXLIVE ROUTINE8-KSalarius Pharmaceuticals, Inc.SLRXLIVE ROUTINE8-KSalarius Pharmaceuticals, Inc.SLRXLIVE ROUTINE4Salarius Pharmaceuticals, Inc.SLRXLIVE Arnold C Hanish, insider filing for SLRX
Arnold C Hanish, reporting
ROUTINE8-KSalarius Pharmaceuticals, Inc.SLRXLIVE ROUTINEPRE 14ASalarius Pharmaceuticals, Inc.SLRXLIVE ROUTINEDEFA14ASalarius Pharmaceuticals, Inc.SLRXLIVE ROUTINE8-KSalarius Pharmaceuticals, Inc.SLRXLIVE ROUTINE4Salarius Pharmaceuticals, Inc.SLRXLIVE Salarius Pharmaceuticals, Inc. - Insider ownership filing (4)
- Insider ownership filing (4)
- Reports beneficial ownership changes
Arnold C Hanish, reporting
ROUTINE4Salarius Pharmaceuticals, Inc.SLRXLIVE Salarius Pharmaceuticals, Inc. - Insider ownership filing (4)
- Insider ownership filing (4)
- Reports beneficial ownership changes
Mark J Rosenblum, reporting
MAJOR8-KSalarius Pharmaceuticals, Inc.SLRXLIVE Salarius Pharmaceuticals, Inc. reported: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
NOTABLE10-QSalarius Pharmaceuticals, Inc.SLRXLIVE